Characteristics | IPE 4 g/day (n = 125) | IPE 2 g/day (n = 124) | Placebo (n = 124) | Total (n = 373) |
---|---|---|---|---|
Age, mean ± SD (years) | 48.5 ± 10.58 | 48.8 ± 10.44 | 49.3 ± 10.13 | 48.9 ± 10.36 |
Age ≤ 65 years, n (%) | 118 (94.4%) | 113 (91.1%) | 116 (93.5%) | 347 (93.0%) |
Men, n (%) | 93 (74.4%) | 93 (75.0%) | 94 (75.8%) | 280 (75.1%) |
Nationality, China (%) | 125 (100.0%) | 123 (99.2%) | 124 (100.0%) | 372 (99.7%) |
Han ethnicity, n (%) | 114 (91.2%) | 116 (93.5%) | 116 (93.5%) | 346 (92.8%) |
Height, mean ± SD (cm) | 169.0 ± 7.76 | 169.1 ± 7.49 | 169.8 ± 7.26 | 169.3 ± 7.49 |
Weight, mean ± SD (kg) | 76.5 ± 11.66 | 75.3 ± 11.91 | 78.4 ± 13.49 | 76.7 ± 12.41 |
Body mass index, mean ± SD (kg/m2) | 26.7 ± 2.75 | 26.2 ± 3.03 | 27.1 ± 3.30 | 26.6 ± 3.05 |
Body mass index < 25, n (%) | 33 (26.4%) | 47 (37.9%) | 33 (26.6%) | 113 (30.3%) |
Statin use | 13 (10.4%) | 13 (10.5%) | 13 (10.5%) | 39 (10.5%) |
Baseline median TG (mmol/L) | 9.470 | 9.215 | 9.270 | 9.370 |
Baseline TG > 8.5 mmol/L | 67 (53.6%) | 68 (54.8%) | 67 (54.0%) | 202 (54.2%) |
Baseline median LDL-C (mmol/L) | 1.420 | 1.290 | 1.360 | 1.360 |
Diabetes mellitus | 23 (18.4%) | 28 (22.6%) | 26 (21.0%) | 77 (20.6%) |
Hypertension | 56 (44.8%) | 64 (51.6%) | 60 (48.4%) | 180 (48.3%) |